Skip to main content
EDX Medical Group Plc logo

EDX Medical Group Plc — Investor Relations & Filings

Ticker · EDX ISIN · GB00BNDMJS47 LEI · 213800BZVJZTMCZ6DJ63 Aquis Stock Exchange Human health and social work activities
Open in API
Filings indexed 116 across all filing types
Latest filing 2026-06-05 Proxy Solicitation & In…
Country GB United Kingdom
Listing Aquis Stock Exchange EDX

About EDX Medical Group Plc

https://edxmedical.com/

EDX Medical Group Plc develops and provides digital diagnostic products and services for healthcare professionals. Its solutions are designed for the rapid detection and characterization of major diseases, enabling personalized treatment and improved patient outcomes. The company's primary focus areas are oncology, cardiology, and infectious diseases. Key offerings in oncology include comprehensive tumour profiling using whole exome and transcriptome sequencing, liquid biopsy analysis, and functional ex vivo assays that predict tumour response to specific therapies. The company also develops highly sensitive tests for early detection of cancers such as prostate and testicular cancer. In infectious diseases, EDX Medical develops point-of-care multiplex tests for conditions like sepsis and pneumonia. The company's approach integrates advanced molecular biology, genomic sequencing, and digital technologies across its laboratory-based services and point-of-care devices.

Recent filings

Filing Released Lang Actions
Posting of Notice of General Meeting
Proxy Solicitation & Information Statement Classification · 91% confidence The document is an RNS announcement titled “Posting of Notice of General Meeting,” stating that the Notice of General Meeting and Form of Proxy will be posted to shareholders and made available electronically. It is a solicitation of votes and provision of proxy materials for the upcoming general meeting, fitting the definition of Proxy Solicitation & Information Statement (PSI).
2026-06-05 English
Rule 17 disclosure
Regulatory Filings Classification · 94% confidence The document is an RNS announcement on the London Stock Exchange titled “Rule 17 disclosure” under AIM rules, providing a regulatory update regarding a director’s outside directorship and related insolvency. It is not an AGM presentation, financial report, earnings release, or specific management report; it is a general compliance/regulatory notification. Therefore it falls under Regulatory Filings (RNS).
2026-06-04 English
Expiration of warrants
Share Issue/Capital Change Classification · 91% confidence The document is an RNS announcement by EDX Medical Group PLC regarding the expiration of warrants and exercise of one warrant resulting in the issue of 150,000 new ordinary shares, along with an updated total share count. This is a corporate action announcement about new share issuance and a capital change. It matches exactly the "Share Issue/Capital Change" category. Therefore, it should be classified as SHA.
2026-06-04 English
First Day of Dealings on AIM
Regulatory Filings Classification · 89% confidence The document is an RNS (Regulatory News Service) announcement by EDX Medical Group PLC regarding the first day of dealings of its ordinary shares on the AIM market. It is a general regulatory announcement rather than a detailed financial report, board change, share issue, or financing detail. It does not contain substantive financial statements or constitute a report itself but serves as a regulatory communication. This aligns with the fallback category for miscellaneous regulatory announcements.
2026-05-13 English
Granting of options over ordinary shares
Director's Dealing Classification · 92% confidence The document is an RNS announcement detailing the grant of share options to directors and senior management, with PDMR tables specifying names, roles, ISIN, volumes, and transaction dates. This is a disclosure of insider dealings by directors (option grants). It is not an annual or quarterly report, nor a dividend or capital raise, but a director share transaction disclosure. Therefore it should be classified as Director's Dealing (DIRS).
2026-04-21 English
Proposed application for admission to AIM
Delisting Announcement Classification · 82% confidence The document is an RNS notice announcing the company’s simultaneous application for admission to trading on AIM and withdrawal of its shares from the Aquis Stock Exchange. It is not an earnings release, annual report, or management discussion but a formal regulatory announcement of a listing change (i.e., delisting from one exchange). This matches the definition of a Delisting Announcement (DLST).
2026-04-13 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.